INVESTEMENT Breakthrough Heart Disease Treatments by Cardiol TherapeuticsBy Editorial teamSeptember 13, 20250 Investor Insight Cardiol Therapeutics is positioned with a late-stage lead asset, multiple orphan indications, strong clinical proof-of-concept data, and a…
